Simultaneous pml-iris after discontinuation of natalizumab in a patient with ms

Neurology

Volumn 79, Issue 21, 2012, Pages 2160-

  Marousi, Stella ^a   Travasarou, Maria ^a   Karageorgiou, Clementine E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NATALIZUMAB;

AGE; CASE REPORT; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MULTIPLE SCLEROSIS; NOTE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELAPSE; TREATMENT WITHDRAWAL;

EID: 84871309340     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000423208.11698.16     Document Type: Editorial

References (6)

1. Gheuens S, Smith DR, Wang X, Alsop DC, Lenkinski RE, Koralnik IJ. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS. Neurology 2012;78: 1390-1393.
2. Bloomgren G, Richman S, Hotermans C, et al. Risk of natalizumab- associated progressive multifocal leukoencephalopathy. N Engl J Med 2012;366:1870-1880.
3. Lenhard T, Biller A, Mueller W, Metz I, Schonberger J, Wildemann B. Immune reconstitution inflammatory syndrome after withdrawal of natalizumab? Neurology 2010;75:831-833.
4. Hellwig K, Gold R. Immune reconstitution inflammatory syndrome after withdrawal of natalizumab? Neurology 2011;76: 1362-1363; author reply 1363.
5. Marousi S, Giannouli E, Karkanis I, Tagaris GA, Karageorgiou CE. Immune reconstitution inflammatory syndrome after withdrawal of natalizumab? Neurology 2011;76:1362-1363; author reply 1363.
6. Gheuens S, Pierone G, Peeters P, Koralnik IJ. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 2010;81:247-254.